Lacunar Intervention Trial 1 (LACI-1) "Prevent-SVD"


Phase 2 Results N/A

Summary of Purpose

Phase II pilot randomised, factorial, short term dose escalation, open label, blinded intermediary endpoint trial, in two hospital centres in the UK, of tolerability and safety of cilostazol, isosorbide mononitrate, both or neither in patients with small vessel disease manifest as symptomatic small subcortical stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 January 2018.

1 Mar 2016 19 Jun 2015 1 Aug 2017 30 Nov 2017 1 Jan 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Factorial Assignment